| 000 | 02513 a2200673 4500 | ||
|---|---|---|---|
| 005 | 20250515054123.0 | ||
| 264 | 0 | _c20070413 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a0887-6924 | ||
| 024 | 7 |
_a10.1038/sj.leu.2404533 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarnes, D J | |
| 245 | 0 | 0 |
_aDifferent target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines. _h[electronic resource] |
| 260 |
_bLeukemia _cMar 2007 |
||
| 300 |
_a421-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdamantane _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBenzoquinones _xadverse effects |
| 650 | 0 | 4 |
_aCell Line, Transformed _xdrug effects |
| 650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
| 650 | 0 | 4 |
_aClone Cells _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
| 650 | 0 | 4 | _aGenes, abl |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aHydroquinones _xadverse effects |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLactams, Macrocyclic _xadverse effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMutant Proteins _xgenetics |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xbiosynthesis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcr _xbiosynthesis |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 | _aReactive Oxygen Species |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aSTAT5 Transcription Factor _xbiosynthesis |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aDe, S | |
| 700 | 1 | _avan Hensbergen, P | |
| 700 | 1 | _aMoravcsik, E | |
| 700 | 1 | _aMelo, J V | |
| 773 | 0 |
_tLeukemia _gvol. 21 _gno. 3 _gp. 421-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2404533 _zAvailable from publisher's website |
| 999 |
_c16814497 _d16814497 |
||